Member Info for TrickyEFC

Over 12p

Bout 8.45😉

Wonder when the market will wake up.

If results are positive.

👀

Now, the new trial, called MORE-KARE, will further test this finding, with the aim of rolling it out into the NHS if the combined treatment proves effective.

Phase 2

Very encouraging data.

The primary outcomes of the trial were 1) Days abstinent in the 6 months after treatment, 2) Relapse at 6 month follow up. The findings showed that ketamine combined with KARE therapy, resulted in total abstinence in 162 of 180 days in the following 6-month period, achieving an increase in abstinence from around 2% prior to the trial to 86% post trial. The results for relapse at 6 months, showed that the Ketamine plus KARE group’s risk of relapse, was 2.7 times less then the placebo plus alcohol education group.

https://awaknlifesciences.com/awakn-announces-positive-results-from-phase-ii-a-b-clinical-trial

After positive phase 2 results phase 3 began in August and subjects are to be monitored for 6months.

More below.

The first patients are now being screened to see if they are eligible to take part in the £2.4 million phase III trial is led by the University of Exeter. The trial will initially be delivered at eight NHS sites across the UK.

The study, called Multicentre Investigation of Ketamine for Reduction of Alcohol Relapse (MORE-KARE), is co-funded by a partnership between the National Institute for Health and Care Research (NIHR), the Medical Research Council (MRC), and biotech company Awakn Life Sciences. It is managed by the Exeter Clinical Trials Unit.

The latest trial builds on positive initial findings of an earlier phase II trial, which showed combined ketamine and therapy treatment was safe and tolerable for people with severe alcohol use disorder. The previous trial found that participants who had ketamine combined with therapy went from drinking every day to remaining sober 86 per cent of the time over a six-month period

Now, the new trial, called MORE-KARE, will further test this finding, with the aim of rolling it out into the NHS if the combined treatment proves effective.

https://news.exeter.ac.uk/faculty-of-health-and-life-sciences/largest-ever-trial-of-ketamine-assisted-therapy-for-alcohol-disorder-now-recruiting/

Nice avo.

Laura let's get past 1p

Enet had a cash raise(new tech) in which they fooked themselves in the ass and we have finally seen the end of the self inflicted sodomy.

Now enet need to do something positive

Could be a good day tomorrow

Surely 😉

Only 1.2 billion shares.

May be slacking thought we was closer to 2 billion.

Relentless buys 🤔

Buying on the drop

A good new year to you Andy.

Very quiet couple of trading days recently.

Lots of holders already in and holding strong (since summer)

William Potts

23.17 %

Oberon Investments Ltd. (GB Investment Management)

8.188 %

Nicholas Nelson

7.296 %

Stuart Sharpless

6.310 %

Paul Levinson

3.267 %

Victor Bolduev

2.308 %

Roby Zomer

0.7214 %

Craig Burton

0.6069 %

Brett Mitchell

0.3427 %

William Murray Mitchell

0.3427 %

Plenty of news flow due in 2025

a week or so ago and accepted it was worth sod all.

now though if it comes back i have no plans in selling unless it goes north of 100p.

i can't be the only one who thought they had lost the lot so now psychological this is a **** walk.

50p per share is a 50 bagger for anyholder given the last 5 months here.

Of buys today.

Nice John.

May be coming before ya know it

Looks like admin have quick of the mark again.

Looks like it's getting taken out